MYRIAD GENETICS, INC. Unrecognized Tax Benefits, Increase Resulting from Acquisition
MYRIAD GENETICS, INC. (MYGN) reported Unrecognized Tax Benefits, Increase Resulting from Acquisition of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition · last filed 2022-02-25
- MYRIAD GENETICS, INC. unrecognized tax benefits, increase resulting from acquisition for fiscal 2021 was $0.00.
- MYRIAD GENETICS, INC. unrecognized tax benefits, increase resulting from acquisition for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- MYRIAD GENETICS, INC. unrecognized tax benefits, increase resulting from acquisition for fiscal 2019 was $2.30M.
- MYRIAD GENETICS, INC. unrecognized tax benefits, increase resulting from acquisition for fiscal 2018 was $0.00.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Acquisition 6 month | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month | Unrecognized Tax Benefits, Increase Resulting from Acquisition 12 month as first filed |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 | ||
| 2020-06-30 | $0.00 10-K · filed 2022-02-25 | ||
| 2019-06-30 | $2.30M 10-K · filed 2022-02-25 | ||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 | ||
| 2014-06-30 | $14.20M 10-K · filed 2016-08-10 | $14.18M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |